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Various mechanisms have been proposed in the past to explain the inability
of the body’s cell mediated immunity (CMI) to cope with the infecting organism in
myco bacterial disease such as leprosy.They include short lived suppressor cells,
n-2 (IL2) defect and Prostaglandin mediated suppression1,2,3. In leprosy
hanisms have been studied using the lymphocyte transformation test (LTT)
to elucidate CMI in vitro.
The present study was designed to study the regulation of CMI in tuberculosis
patients and normal individuals with regard to induction, expression, inhibition and
modulation due to prior exposure to environmental mycobacteria.
Patients: All patients included in this study were previously untreated
smear and culture positive cases attending out-patient clinic at Tuberculosis Research
Centre (TRC), Madras.
: Volunteers from the staff members of the TRC were included as
normal healthy controls.
                                                From tuberculosis patients and normal
subjects, 20 ml. of peripheral blood was drawn and the lymphocytes were isolated by
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Ficoll Hypaque density gradient centrifugation. Ficoll Hypaque or Lymphocyte
separation medium (LSM, Bionetics, Kensington, Maryland 20795, U.S.A.) was
overlayered with peripheral blood, in a ratio of1 : 1, and centrifuged at 1508 rpm for
30 minutes.Lymphocytes were removed from the interphase, washed thrice with
Hank’s balanced salt solution and adjusted to a density of 0.5 x 106 cells/ml in
RPMI-1640 (Grand Island Biological Company,New York, U.S.A.) after assessing
the viability of the lymphocytes using the Trypan Blue dye exclusion method. The
viability of the cells was around 95%.
Cells were cultured in 0.2 ml of RPMI-1640 supplemented with Penicillin
(100 IU/ml of medium), Streptomycin (100 µg/ml), Glutamine (300 µg/ml) and 10%
autologous plasma in 96-well U-bottomed tissue culture plates.(Dynatech Labora-
tories, Inc., Alexandria, Virginia, U.S.A.)
The cultures were stimulated with mitogens Phytohaemagglutinin (PHA)
5 µg/ml (Wellcome Reagents Ltd.,Bakenham, England), Phorbal Myristic Acid
(PMA) 600 µg/ml and Conconavalin-A 50 µg/ml (Con-A) (Sigma Chemical Co.,
St. Louis, MO, U.S.A.).
The antigens used were M. tuberculosis H37Rv, M. tuberculosis 7219-South
Indian strain, British strain of M. tuberculosis S1, M. bovis, M. scrofulaceum, M.
kansasii, M. fortuitum, M. terrae, M. avium intracellulare serotype 8 (S8), M. chelonei,
M. flavescens, M. bovis (BCG) and purified protein derivative of M. tuberculosis (PPD)
(gift from the Ministry of Agriculture, Fisheries & Food, Weybridge, England).All
mycobacterial antigens were used at a concentration of 10 ug/ml.The preparation
of these antigens is as described in the previous paper.Optimal concentrations of
the antigens as well as optimal length of incubation period of the culture were fixed
from prior standardisation experiments with normal subjects. Whenever the batch
of the mitogens or antigens was changed, the dosages were checked.
Mitogen-stimulated cultures as well as antigen-stimulated cultures were
incubated at 37°C in an atmosphere of 5% CO2 for 144 hrs. The proliferative
response was measured after adding 1.0 uCi of 3H–Thymidine (Specific activity
13,000 uCi/mm) (Bhabha Atomic Research Centre, Bombay) and incubating for a
further period of 18 hours at 37°C before harvesting.
Cells were harvested with multiple automatic specimen harvester-Mash-II
(Microbiological Associates,U. S. A.) and deposited on glass tissue filter paper
(Whatman Inc., Litton, NJ., U.S.A.).These paper discs were transferred to biovials
(Beckman instruments Inc., California, U.S.A.), with 2.5 ml of scintillation fluid
containing 4.0 g/litre of PPO and 0.05 g/litre of POPOP (Sigma Chemical Company,
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St. Louis, MO, U.S.A.) in toluene and counted for 30 seconds in Packard Tricarb-300
(Packard Instruments Inc., III., U.S.A.).
Removal of adherent cells : Total mononuclear cells from the patients and
the normal volunteers were seeded in plastic petri dishes.The cells were supplemented
with 10% heat inactivated (for 30 minutes at 56°C) pooled normal human serum and
incubated at 37°C for 90 minutes in 5% CO2 atmosphere.The supernatant contain-
ing the non-adherent cells was removed.No effort was made to wash and take out
the loosely bound cells.The cell density of the non-adherent cells was adjusted to
be 0.5 x 106 cells/ml.
Short lived suppressor cells in-vitro : Mononuclear cells from the patients and
the volunteers were cultured in the absence of antigen or mitogen for 24 hours or
48 hours.After 24 or 48 hours, the antigens and mitogens were added to the culture
and LTT was done as described above.
Co-stimulation with antigen : LTT was done with PBMNC in the presence of
M. tuberculosis H37Rv alone and H37Rv along with the following antigens ; M. tuber-
culosis 7219, M. scrofuloceum, M. avium intracellulare serotype 8, M. bovis (BCG), and
M.flavescens. All these antigens were added in 10 µg/ml concentrations. Also
PBMNC of tuberculosis patients and volunteers were cultured in-vitro in the presence
of 20 µg/ml of mycobacterial antigens along with any one of the following three
doses of Con-A, 5 µg/ml, 10 µg/ml and 20 µg/ml.
Experiments with indomethacin : PBMNC and non-adherent cells were
separately cultured with M. scrofulaceum,M. bovis (BCG) M. avium intracellulare
serotype 8, M. chelonei and M. tuberculosis H37Rv in the presence and absence of
indomethacin 1 mg/ml.
Results
The mean log cpm ± SD of 1.5 tuberculosis patients and 12 volunteers to
PHA, Con-A and PMAwere4.4 ± 0.4; 3.1 ± 0.6and4.0 ± 0.6; 3.4 ± 0.8and
40 ±0.7 respectively.
There was significantly lower blastogenic response to Con-A in tuberculosis
patients than in volunteers. Between the two groups no significant difference was
seen in the blastogenic response to PHA and PMA (Figs. 1, 2 and 3).
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PROLIFERATIVE RESPONSE OF PBMNC
TO PHA IN VOLUNTEERS AND TB PATIENTS
Figure–1.
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PROLIFERATIVE RESPONSE OF PBMNC
TO CON A IN VOLUNTEERS AND TB PATIENTS
Figure–2
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PROLIFERATIVE RESPONSE OF PBMNC
TO PMA IN VOLUNTEERS AND TB PATIENTS
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PROLIFERATIVE RESPONSE OF VOLUNTEERS TO MYCOBACTERIAL
2 0 ANTIGENS
Figure–4
PROLlFERATIVE RESPONSE OF TB PATIENTS TO MYCOBACTERIAL
2 0 ANTIGENS
Figure–-5
Among patients, a stimulation index of less than 2.0 was seen in 7 out of 23
patients to M. tuberculosis 7219, PPD and M. terrae, 15 out of 22 patients to M. scro-
fulaceum, 10 out of 15 patients to M. kansasii,12 out of 22 patients to M. avium
intracellulare serotype 8, 8 out of 21 patients to BCG, 9 out of 15 patients to M. flave-
scens and 6 out of 15 patients to M. tuberculosis H37Rv. Thus more number of patients
showed suppression to mycobacterial antigens than volunteers.Hence investigations
were extended to learn the nature of suppressive response of the PBMNC from tuber-
culosis patients to various antigens.
Short lived suppressor cells :
Various mycobacterial antigens wereadded to PBMNC cultures from 3
patients at 0 and 24 hours after initiation of the culture.It is seen from figure 6 that
preculture for 24 hours before the addition of antigensdid not cause any consistent
enhancement in the response.
Table – 1
The effect of delaying the addition of mitogens for 48 and 144 hrs
on the proliferative responses of PBMNC from patients and from
normal volunteers.
Mitogcns
48 hours 144 hours
Normal Patients Normal Patients
volunteers Volunteers
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PROLIFERATIVE RESPONSE OF PBMNC TO THE ANTIGENS
ADDED AT 0 Hr AND 21 Hrs
F igure–6
1. M. tuberculosis- 7219 2. M. bovis 3. M. scrofulaceum 4. M. kansasii
5. M. fortuitum 6. M. avium intracellulare7. M. tuberculosis- S.I. 8. M. terrae
9. M. bovis BCG 10. M. chelonei 11. M. flavescens 12. M. tuberculosis H37Rv
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Table–2
The effect of delaying the addition of homologous antigens for 48 and
144 hrs. on the proliferative responses of peripheral blood mononuclear
cells from patients and from normal volunteers.
48 Hrs.             144 Hr.
Normal Patients Normal Patients
volunteers volunteers
M. tuberculosis- 7219 5/6 2/6 2/10 3/8
M. tuberculosis- SI Strain 1/6 2/6 0/10 2/8
M. tuberculosis- H37Rv 4/6 1/6 2 / 9 0/7
PPD-S 3/6 1/6 2/10 0/7
No. of individuals showing enhanced responses when mitogen addition was delayed for
either 48 or 144 hrs. (over total number tested).
Table–3
The effect of delaying the addition of other mycobacterial antigens on the
proliferative responses of PBMNC from patients and normal volunteers.
Antigens
48 Hrs.
Normal Patients
144 Hrs.
Normal Patients
volunteers volunteers
M. bovis 5/6
M. scrofulaceum 3/6
M. kansasii 4/6
M. fortuitum 4/6
M. avium intracellulare 5/6
M. terrae 4/6
BCG 1/6
M. chelonei 2/6
M. flavescens 4/6
0/2
1/2
0/2
0/2
0/2
1/2
0/2
1/2
1/2
2/9 2/8
0/9 3/8
1/5 3/8
1/5 1/8
0/9 2/8
0/5 2/8
0/9 2/8
0/5 1/3
1/5 0/3
No. of individuals showing enhanced responses when mitogen addition was delayed for either
48 or 144 hrs., (over total number tested).
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Effect of Addition of Indomethacin :
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Out of a total of 4 volunteers and 3 patients the proliferative response of
PBMNC from all 4 volunteers and 2 patients was enhanced by the addition of indo-
methacin. (Tables 4 and 5).This was observed with respect to various antigens like
S. Indian isolate M. tuberculosis 7219, M. scrofulaceum, M. avium intracellulare
serotype 8, M. bovis (BCG), M. chelonei and M. flavescens. However, in one of the
tuberculosis patients where antigen induced proliferation was minimal, indomethacin
could not induce or enhance proliferation of the cells.
Table–4
The effect of addition of indomethacin (1 µg/ml) on day ‘0’ on the proliferative
responses of PBMNC from four normal volunteers.
Soluble Antigen Individual
(20 µg/ml) tested
Mean D counts per minute per culture ± S.D.
Antigen alone + Indomethacin
M. tuberculosis- 7219
M. scrofulaceum
M. avium intracellulare
serotype-8
M. bovis BCG
M. chelonei
M. flavescens
1
2
3
4
1
2
3
4
1
2
3
4
1
2
3
4
1
2
3
4
1
2
3
4
36276± 10718
117900± 2536
32463± 14268
99050± 9042
33953± 14813
50416± 2559
28010± 15410
57156± 11492
19743± 4655
47886± 3857
25196± 3743
55873± 13978
25343± 7117
103166± 7983
15565± 5621
77916± 19936
25590± 5586
34520± 9889
37596± 10625
40090± 12682
5545± 572
30516± 4253
10890± 1626
20320± 5489
47358± 16491
127736± 17244
53026± 2277
120340± 4601
48896± 5375
82043± 2624
53 190± 1027
98826± 12240
26026± 9381
76076± 9472
28326± 7240
74650± 17154
34983± 2630
128535± 6450
53570+ 1612
119969± 2483
39536± 6501
43710± 4758
39123± 25525
68866± 20273
10180± 1943
55856± 12991
31995± 1647
45430± 8486
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Table– 5
The effect of addition of indomethacin (1 µg@ml) on day ‘0’ on the prolifer-
ative responses of PBMNC from three tuberculosis patients.
Soluble Antigen
(20 µg/ml)
Individual
tested
Mean D counts per minute per culture ± S.D.
Antigen alone + Indomethacin
M. tuberculosis– 7219
M. scrofulaceum
M. avium.
intracellare
serotype– 8
M. bovis BCG
M. chelonei
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1.5548 ± 4218
3631 ± 1779
5441 ± 676
4775 ± 916
1830 ± 714
4711 ± 1296
7675 ± 3814
2835 ± 219
6703 ± 5451
14556± 5575
4672±  521
7790± 1687
7675± 3814
2439± 40
2743±    305
2876± 1543
2342± 1181
3611 ± 1378
25944±  2580
4243±    759
10417± 4113
9409 ± 2959 
2653± 1102
9496± 1797
6577± 2266
1768±    561
8369± 1467
24470± 2340
10112± 14414
17994± 4516
7831± 3382
2822±   202
6377± 1902
2979± 1054
3624±  6 6 4
6933± 1460
Effect of indomethacin addition on non-adherent cells :
In 3 patients, from the total PBMNC theadherent cells were removed by
plastic adherence.The resulting non adherent cells and total PBMNC were cultured
in the presence of antigens and indomethacin.Indomethacin failed to cause enhance-
ment of responses of non-adherent cells (Table–6).The results are expressed in
absolute counts.
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Table– 6
The effect of addition of indomethacin (1 µg/ml) on day ‘0’ on the prolifer-
ative responses of total PBMNC and non-adherent cells from 3 tuberculosis
patients.
Soluble Individual
Antigen tested
Total cells Non-adherent cells
Ag. alone + Indo Ag. alone + Indo
M. tuberculosis
M. scrofulaceum
M. avium-
intracellulare
serotype-8
M. bovis BCG
M. chelonei
M. flavescens
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
15548 25944
3631 4243
5441 10217
4775 9409
1830 2653
4711 9496
7675 6577 2262
2835 1768 3259
6703 8369 –
2048
2073
14556 24470
4672 10112
7790 17994
6115 5410
5682 4462
7675 7871 2278 1898
2439 2822 2444 2328
2743 2743 2987 2387
2876 2979 2783 2236
2342 3624 2237 2340
3611 6933 1933 1992
2454 2249
8847 6308
4485 4474
2646 3855
2657 3470
3703 3178
Co-stimulation of PBMNC with various mycobacterial antigens with M. tuberculosis
H37Rv :
The results of co-stimulation experiments with mycobaterial antigen are
expressed as percent inhibition in figure 7.It was seen that BCG and M. chelonei
induced less suppression when compared to M. scrofulaceum, M. avium intracellulare
serotype 8 and M,. flavescens.
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COSTIMULATION OF PBMNC WITH VARIOUS ENVIRONMENTAL
MYCOBACTERIA AND M. Tuberculosis H37 RV
Figure– 7
Inhibition of the M. tuberculosis H37Rv response by (A) M. scrofulaeum, (B) M. bovis
BCG, (C) M. avium intracellulare, (D) M. chelonei, (E) M. flavescens, using PBMNC from
normal volunteers (•) and pulmonary tuberculosis patients (o).
Percentage
inhibition
= 100 – net cpm of A&B  x 100
Net cpm A + Net cpm B
cpm AB = Net response obtained when M. tuberculosis H37Rv and another antigen
added together.
cpm A & cpm B     =  Net responses obtained in cultures stimulated respectively by M. tubercu-
losis H37RV and the second antigen.
Figure 8 represents percent response of PBMNC to 20 µg/ml of Con-A and
Con-A along with mycobacterial antigens. The response of patients and volunteers to
Con-A were not uniformly inhibited by the addition of mycobacterial antigens and
enhancement was seen in a few volunteers and patients. This was observed with all
the three doses of Con-A. (5 µg/ml, 10 µg/ml and 20 µg/ml).
COSTIMULATION OF PBMNC WITH CON A AND
ENVIRONMENTAL MYCOBACTERIA 5 µg/ml
Figure– 8
Percentage of Con-A response in lymphocytes stimulated with (A) M. tuberculosis- 7219
(B) M. scrofulaceum (C) M. avium intracellulare (D) M. bovis BCG and (E) Con-A (20 µg)
for 6 days from normal volunteers (o) and patients with pulmonary tuberculosis (•).
Though the effector functions of the proliferating cells and their relationship
to immunity is unknown, a number of observations suggest that this type of response
does atleast correlate with inflammatory activity in the lesions of leprosy patients
and hence the regulation of proliferative response is of great relevence4,5.
In the present study PBMNC of the tuberculosis patients who showed normal
responses to PHA showed decreased proliferative response to PMA and Con-A.The
decrease in Con-A response was statistically significant. This decreased response is
not due to toxicity because the same concentration of Con-A induced proliferative
response in PBMNC of normal volunteers cultured in vitro. Reasons for the prefe-
rential reactivity to one or the other of thse mitogens is not known.In man,
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Con-A reactivity has been shown to be moresensitive to macrophage T cell
interactions than PHA reactivity.Then it probably means that the lower response
to Con-A in patients with tuberculosis reflects some abnormality at the level of
macrophage.Ellner et al 7 showed that depletion of adherent cells enhance in vitro
responsiveness of T lymphocyte to tuberculin thus demonstrating the presence of
adherent suppressor cells.
Delaying the addition of antigen1 or Con-A8 has been shown to increase
proliferative response.Bahr et al 9 showed that the proliferative response of PBMNC
from tuberculoid (TT) and borderline leprosy (BL) cases and normal subjects were
enhanced by delaying the addition of antigens to the LTT system which suggested a
role for short lived suppressor cells.In our studies, the increase after delayed
addition of various mitogens and antigens was seen only in a small percentage of
volunteers and patients. Thus there was no evidence for the presence of specific
regulator cells of short lived nature i  vitro.
From the data it is difficult to conclude whether the responses from normal
individuals to antigens of M. tuberculosis and other mycobacterial strains represent
responses to common antigens of mycobacteria and/or represent true sensitization
with individual strains. The high prevalence of environmental mycobacteria in this
area increases the complexity of the problem10.
Addition of indomethacin enhanced antigen induced proliferation in all the
four normal individuals and in two patients.All the mycobacterial antigens showed
the same effect. But when the basal antigen induced proliferation was low, indome-
thacin could not enhance it.The absence of this normal regulatory mechanism from
the PBMNC of certain tuberculosis patients could be either due to failure of the
antigens to induce synthesis or release of prostagladin E2 (PGE2) or the absence of
target calls upon which the PG acts.It was also further observed that indomethacin
failed to cause enhancement of response of non-adherent cells. This finding is
consistent with the reported view that ceils of the monocyte/macrophage series are the
main source of PGE-2 in vitro 8,11.
The hyporesponsiveness of cells from certain patients is not due to excessive
PGs in vitro and there is no difference in the pattern of response to indomethacin
among the various mycobacterial antigens tasted.
In costimulation experiments, inhibition of Con-A responses were not uniform
and frequently, enhancement rather than inhibition was observed.This was observed
with all three doses of Con-A.There was no specific pattern with any of the myco-
bacterialantigens used.Similar observations have been reported by Bahr et al who
used M. tuberculosis, M. kansasii, M. leprae, M. vaccae and M. nonchromogenicum
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with and without Con-A in their lymphoproliferative assay using PBMNC from
normal individuals.
Costimulation of PBMNC by various mycobacterial antigens along with
M. tuberculosisH37Rv revealed that the proliferation responses of PBMNC of both
tuberculosis patients and volunteers toH37Rv were suppressed by the various
environmental mycobacteria used.Th refore, any suppressive effect of these antigens
on the cell mediated immunity of tuberculosis patients may not depend on an
enhanced susceptibility of their PBMNC to these antigens.The r a ons for this effect
may be antigenic activity of the common mycobacterial components such as the cell
wall glycopeptide or peptidoglycolipid and/or may be mediated by suppressor cells
triggered by the shared antigens.This observation is strengthened by the study of
Wadee et al showing au extractable lipid rich component of whole organisms involved
in suppression.12
1.
2.
3.
4.
5.
6.
7.
a.
Smith KA. As cited in Production and assay of the interleukines.J. Immunol
Methods, 1985 ; 83 : 1.
Lomnitzer R, Rabson, AR, Koornhof HJ. The effects of cyclic AMP on
leucocyte inhibitory factor (LIF) production and on the inhibition of leucocyte
migration. Clin exp Immunol, 1976, 21 : 42.
Stobe JD, Paul S, Vanscoy RE, Hermans PE. Suppressor thymus derived
lymphocytes in fungal infection.J Clin Invest, 1976 ; 57 : 319.
Barnetson RStc, Barnestson A, Pearson MH, Kronvall G. Does non-specific
T-lymphocyte stimulation of B-lymphoytes occur during reversal reaction in
borderline leprosy.Scand J Immunol, 1976 ; 5 : 287.
Bjune G, Barnetson RStc, Ridley DS, Kronvall G. Lymphocyte transformation
test in leprosy : Correlation of the response with inflammation of lesions. Clin
exp Immunol, 1976 ; 25 : 85.
Stobo JD. Mitogens In : Clinical Jmmunology, 1980 ; 4 : 55.
Ellner JJ. Suppressor adherent cells in human tuberculosis. J Immunol. 1978a ;
121 : 2573.
Raff HV, Cochrum KC, Stobo JD. Macrophage T-cell interactions in the
Con-A induction of human suppressive T-cells.J Immunol, 1978 ; 12 : 97.
CMI Response of . . . Antigens by LTT 101
9.
10.
11.
12.
Bahr GM, Rook GAW, Stanford JL. Inhibition of proliferative response of
peripheral blood lymphocytes to mycobacterial or fungal antigens by co-stimu-
lation with antigens from various mycobacterial species.Immunol, 1981 ;
44 : 593.
Paramasivan CN, Govindan D, Prabhakar R, Somasundaram PR, Subbammal
S, Tripathy SP. Species levels identification of non-tuberculosis mycobacteria
from South Indian BCG Trial area during 1981.Tubercle, 1985 ; 66 : 9.
Ellncr JJ, Spagnuolo PJ.Suppression of antigen and mitogen induced human
T-lymphocyte DNA synthesis by bacterial lipopolysaccharide mediation by
monocyte activation and production of prostaglandins. J Immunol, 1979 ;
123 : 2689.
Wadee AH, Sher R, Rabson ARProduction of a suppressor factor by human
adherent cells treated with mycobacteria. J Immunol, 1980; 125 : 1380.
